Administration of Banked, 3rd Party Multivirus-Specific T Cells to Treat Drug-Refractory EBV, CMV, AdV, HHV6, and BKV Infections in Allogeneic Hematopoietic Stem Cell Transplant Recipients
2017 ◽
Vol 23
(3)
◽
pp. S58-S59
2009 ◽
Vol 45
(3)
◽
pp. 543-549
◽
2016 ◽
Vol 98
◽
pp. 62-72
◽
2012 ◽
Vol 18
(2)
◽
pp. S219
◽
2018 ◽
Vol 5
(suppl_1)
◽
pp. S480-S480
◽
2007 ◽
Vol 11
(7)
◽
pp. 736-742
◽